82 related articles for article (PubMed ID: 35476232)
41. Direct multiplexed measurement of gene expression with color-coded probe pairs.
Geiss GK; Bumgarner RE; Birditt B; Dahl T; Dowidar N; Dunaway DL; Fell HP; Ferree S; George RD; Grogan T; James JJ; Maysuria M; Mitton JD; Oliveri P; Osborn JL; Peng T; Ratcliffe AL; Webster PJ; Davidson EH; Hood L; Dimitrov K
Nat Biotechnol; 2008 Mar; 26(3):317-25. PubMed ID: 18278033
[TBL] [Abstract][Full Text] [Related]
42. GSEA-P: a desktop application for Gene Set Enrichment Analysis.
Subramanian A; Kuehn H; Gould J; Tamayo P; Mesirov JP
Bioinformatics; 2007 Dec; 23(23):3251-3. PubMed ID: 17644558
[TBL] [Abstract][Full Text] [Related]
43. The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas.
Natkunam Y; Zhao S; Mason DY; Chen J; Taidi B; Jones M; Hammer AS; Hamilton Dutoit S; Lossos IS; Levy R
Blood; 2007 Feb; 109(4):1636-42. PubMed ID: 17038524
[TBL] [Abstract][Full Text] [Related]
44. RhoGTPases and p53 are involved in the morphological appearance and interferon-alpha response of hairy cells.
Chaigne-Delalande B; Deuve L; Reuzeau E; Basoni C; Lafarge D; Varon C; Tatin F; Anies G; Garand R; Kramer I; Génot E
Am J Pathol; 2006 Feb; 168(2):562-73. PubMed ID: 16436670
[TBL] [Abstract][Full Text] [Related]
45. Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs.
Shen Y; Iqbal J; Xiao L; Lynch RC; Rosenwald A; Staudt LM; Sherman S; Dybkaer K; Zhou G; Eudy JD; Delabie J; McKeithan TW; Chan WC
BMC Immunol; 2004 Sep; 5():20. PubMed ID: 15369600
[TBL] [Abstract][Full Text] [Related]
46. Comparative expressed sequence hybridization studies of hairy cell leukemia show uniform expression profile and imprint of spleen signature.
Vanhentenrijk V; De Wolf-Peeters C; Wlodarska I;
Blood; 2004 Jul; 104(1):250-5. PubMed ID: 15016649
[TBL] [Abstract][Full Text] [Related]
47. Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors.
Basso K; Liso A; Tiacci E; Benedetti R; Pulsoni A; Foa R; Di Raimondo F; Ambrosetti A; Califano A; Klein U; Dalla Favera R; Falini B
J Exp Med; 2004 Jan; 199(1):59-68. PubMed ID: 14707115
[TBL] [Abstract][Full Text] [Related]
48. RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13.
Shi GX; Harrison K; Wilson GL; Moratz C; Kehrl JH
J Immunol; 2002 Sep; 169(5):2507-15. PubMed ID: 12193720
[TBL] [Abstract][Full Text] [Related]
49. Increased expression of the PRAD-1/CCND1 gene in hairy cell leukaemia.
Bosch F; Campo E; Jares P; Pittaluga S; Muñoz J; Nayach I; Piris MA; Dewolf-Peeters C; Jaffe ES; Rozman C
Br J Haematol; 1995 Dec; 91(4):1025-30. PubMed ID: 8547115
[TBL] [Abstract][Full Text] [Related]
50. The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes.
Matutes E; Morilla R; Owusu-Ankomah K; Houliham A; Meeus P; Catovsky D
Leuk Lymphoma; 1994; 14 Suppl 1():57-61. PubMed ID: 7820054
[TBL] [Abstract][Full Text] [Related]
51. Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy.
Maitre E; Cornet E; Debliquis A; Drenou B; Gravey F; Chollet D; Cheze S; Docquier M; Troussard X; Matthes T
J Cancer Res Clin Oncol; 2022 Aug; 148(8):2013-2022. PubMed ID: 35476232
[TBL] [Abstract][Full Text] [Related]
52. Hairy cell leukemia: update and current therapeutic approach.
Salam L; Abdel-Wahab O
Curr Opin Hematol; 2015 Jul; 22(4):355-61. PubMed ID: 26049757
[TBL] [Abstract][Full Text] [Related]
53. Update on the biology and treatment options for hairy cell leukemia.
Jain P; Pemmaraju N; Ravandi F
Curr Treat Options Oncol; 2014 Jun; 15(2):187-209. PubMed ID: 24652320
[TBL] [Abstract][Full Text] [Related]
54. New insights in the management of patients with hairy cell leukemia.
Cornet E; Damaj G; Troussard X
Curr Opin Oncol; 2015 Sep; 27(5):371-6. PubMed ID: 26154707
[TBL] [Abstract][Full Text] [Related]
55. Clinicopathological spectrum of hairy-cell leukemia: A single-center study with brief review of Indian literature.
Gupta R; Yadav S; Mittal N; Rahman K; Sharma A; Gupta A; Nityan S
J Cancer Res Ther; 2020; 16(1):120-126. PubMed ID: 32362621
[TBL] [Abstract][Full Text] [Related]
56. Deciphering the genotype and phenotype of hairy cell leukemia: clues for diagnosis and treatment.
Polderdijk MCE; Heron M; Kuipers S; Rijkers GT
Expert Rev Clin Immunol; 2019 Aug; 15(8):857-867. PubMed ID: 31282776
[No Abstract] [Full Text] [Related]
57. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment.
Maitre E; Cornet E; Troussard X
Am J Hematol; 2019 Dec; 94(12):1413-1422. PubMed ID: 31591741
[TBL] [Abstract][Full Text] [Related]
58. BRAF in the cross-hairs.
Geyer MB; Abdel-Wahab O; Tallman MS
Expert Rev Hematol; 2019 Mar; 12(3):183-193. PubMed ID: 30782032
[TBL] [Abstract][Full Text] [Related]
59. BRAF V600E mutation in hairy cell leukemia: from bench to bedside.
Falini B; Martelli MP; Tiacci E
Blood; 2016 Oct; 128(15):1918-1927. PubMed ID: 27554081
[TBL] [Abstract][Full Text] [Related]
60. Historical overview of hairy cell leukemia.
Andritsos LA; Grever MR
Best Pract Res Clin Haematol; 2015 Dec; 28(4):166-74. PubMed ID: 26614894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
